PTN
PTN
AMEX · Biotechnology

Palatin Technologies Inc

$9.58
-0.52 (-5.10%)
As of Sep 28, 10:35 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +38.5% upside
Low Target $11.80
Average Target $13.27
High Target $20.48
Current Price $9.58
Current
$9.58
Target
$13.27
$11.80 $13.27 avg $20.48
Scenario Analysis
Bear Case
$11.80
23.2%
Low target
Base Case
$13.27
+38.5%
Avg target
Bull Case
$20.48
+113.8%
High target
Risk/Reward
4.9x
Highly favorable
Price in Context
52-Week High
$31.00
-69.1% from high
52-Week Low
$5.61
+70.8% from low
Target vs 52W High
$13.27
-57.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%